Friedman School of Nutrition Science and Policy at Tufts University, recently served as lead chair and author of a clinical advisory titled Nutritional Priorities to Support GLP-1 Therapy for Obesity, published across four peer-reviewed journals and issued by four leading organizations in lifestyle medicine, obesity medicine, and nutritionthe American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)
Please enable JavaScript to view this page.
Protein at every meal is especially important reduced appetite on GLP-1 therapy creates a real risk of muscle loss if protein intake drops too low
Bundle pricing from $99/month on the 12-month plan, plus a microdosing option for gentler titration
This, combined with the side effects of oral Wegovy or Rybelsus, like vomiting or diarrhea, could result in dehydration
While the therapeutic benefits of GLP-1RAs in diabetes management are well-established, their emerging role in other diseases suggests novel treatment strategies
